27 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25794791	13	Recent advances in the chemistry and biology of pyridopyrimidines.	Universit£
25259627	36	Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.	Academy Of Sciences Of The Czech Republic
15149648	32	A TOPS-MODE approach to predict adenosine kinase inhibition.	Vigo University
18077363	314	A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.	University Of Oxford
15214773	76	Fragment-based drug discovery.	Sunesis Pharmaceuticals
8230132	7	New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.	University Of California
3351857	1	Synthesis, intramolecular hydrogen bonding, and biochemical studies of clitocine, a naturally occurring exocyclic amino nucleoside.	Nucleic Acid Research Institute
21711054	16	Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.	Academy Of Sciences Of The Czech Republic
21319802	51	Non-nucleoside inhibitors of human adenosine kinase: synthesis, molecular modeling, and biological studies.	Universita` Di Siena
20055427	98	Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.	Metabasis Therapeutics
19348494	73	Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.	Metabasis Therapeutics
17197188	110	4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.	Abbott Laboratories
16302820	45	Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.	Metabasis Therapeutics
16190769	23	Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.	Metabasis Therapeutics
15911258	45	Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.	Abbott Laboratories
15857145	22	Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.	Metabasis Therapeutics
15261263	14	Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors.	Abbott Laboratories
15050645	35	Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis.	Bayer
14613327	46	5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.	Abbott Laboratories
14561094	20	Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.	Metabasis Therapeutics
12941329	30	Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity.	Abbott Laboratories
11958989	32	QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.	Jadavpur University
11514141	16	Pyridopyrimidine analogues as novel adenosine kinase inhibitors.	Abbott Laboratories
11405650	42	Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..	Abbott Laboratories
11123986	5	Design of adenosine kinase inhibitors from the NMR-based screening of fragments.	Abbott Laboratories
10956197	34	Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.	Metabasis Therapeutics
10956196	39	Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.	Metabasis Therapeutics